*This was observed when Evrysdi was studied in animals.
SMN=survival motor neuron.
*Based on individuals with SMA receiving Evrysdi worldwide as of August 2024.
†Clinical trials of Evrysdi did not include people aged 65 and older to determine whether they respond differently from those who are younger.
Información de prescripción de Evrysdi® (risdiplam). Genentech, Inc.
Información de prescripción de Evrysdi® (risdiplam). Genentech, Inc.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.